Erythema nodosum in Behçet’s disease in remission: Think COVID-19?

Loading...
Thumbnail Image

Date

Journal Title

Journal ISSN

Volume Title

Publisher

SAGE Publications Ltd

Abstract

The coronavirus disease has several manifestations related to the activation of the immune system. Because of such activation, autoimmune diseases, including vasculitis, have been reported to occur. Behçet’s disease, a variable vessel vasculitis, has been discussed in the context of coronavirus disease. Rarely, the induction of Behçet’s disease flare or exacerbation has been reported necessitating aggressive treatment. The presentation of Behçet’s disease flares secondary to coronavirus disease is variable, including mucocutaneous lesions and eye or joint involvement. We highlight the case of a 35-year-old woman with pre-existing Behçet’s disease in remission on colchicine presenting with new onset erythema nodosum-like lesions on her right shin being diagnosed with coronavirus disease infection a few days after. Despite treatment with systemic corticosteroid, the lesions did not resolve, necessitating the initiation of anti-interleukin-6 therapy. © The Author(s) 2023.

Description

Keywords

Behçet’s disease, Coronavirus disease, Erythema nodosum, Positron-emission tomography imaging, Clopidogrel, Colchicine, Corticosteroid, Fluorodeoxyglucose f 18, Hla b51 antigen, Prednisolone, Tocilizumab, Adult, Arthralgia, Article, Behcet disease, Carotid intima-media thickness, Case report, Clinical article, Computer assisted tomography, Coronavirus disease 2019, Coughing, Doppler ultrasonography, Erythema, Female, Follow up, Human, Hypopyon, Iridocyclitis, Jaw pain, Mouth ulcer, Pain, Positron emission tomography, Positron emission tomography-computed tomography, Posterior tibial artery, Remission, Severe acute respiratory syndrome coronavirus 2, Skin defect, Subsartorial artery, Vasculitis

Citation

Endorsement

Review

Supplemented By

Referenced By